SAVA

Cassava Sciences, Inc.

2.04

USD

SAVA Earnings Reports

Positive Surprise Ratio

SAVA beat 19 of 29 last estimates.

66%

Next Report

Date of Next Report

Mar 03, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.30

Implied change from Q3 25 (Revenue/ EPS)

+36.36%

Implied change from Q4 24 (Revenue/ EPS)

-46.43%

Cassava Sciences, Inc. earnings per share and revenue

On Nov 12, 2025, SAVA reported earnings of -0.22 USD per share (EPS) for Q3 25, beating the estimate of -0.27 USD, resulting in a 20.12% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.82% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.30 USD, with revenue projected to reach -- USD, implying an increase of 36.36% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Jan 30, 2026 For Q3 26

Estimate

$34.44

Actual

$65.64

Surprise

+90.61%

FAQ

What were Cassava Sciences, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Cassava Sciences, Inc. reported EPS of -$0.22, beating estimates by 20.12%, and revenue of $0.00, 0% as expectations.

How did the market react to Cassava Sciences, Inc.'s Q3 2025 earnings?

The stock price moved up 4.82%, changed from $3.11 before the earnings release to $3.26 the day after.

When is Cassava Sciences, Inc. expected to report next?

The next earning report is scheduled for Mar 03, 2026.

What are the forecasts for Cassava Sciences, Inc.'s next earnings report?

Based on 3 analysts, Cassava Sciences, Inc. is expected to report EPS of -$0.30 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.